Description of Organization and Business Operations (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jan. 10, 2020 |
Mar. 04, 2019 |
Aug. 19, 2019 |
Jun. 22, 2018 |
Apr. 30, 2018 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Sale of units per share | $ 10.20 | |||||||
| Sale of units in initial public offering aggragate amount | $ 155,250,000 | |||||||
| Deferred underwriting commissions | $ 5,433,750 | 5,433,750 | ||||||
| Offering costs | 9,295,693 | |||||||
| Cash placed in a trust account | $ 162,019,909 | 159,718,098 | ||||||
| Percentage of asset held in trust account | 80.00% | |||||||
| Business combination, percentage of voting securities | 50.00% | |||||||
| Tax obligation, maximum amount | $ 100,000 | |||||||
| Business Combination, minimum amount of net tangible assets | 5,000,001 | |||||||
| Cash | 161,405 | $ 196,804 | $ 19,538 | |||||
| Woking capital | $ 477,000 | |||||||
| Working capital loan repayment description | The Working Capital Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. On March 4, 2019, the Company issued a convertible note (“Convertible Note”) to the Sponsor, pursuant to which the Sponsor agreed to provide a Working Capital Loan to the Company of up to $1.5 million. The Company was provided $400,000 and $350,000 in loan proceeds on March 4, 2019 and August 19, 2019, respectively, for an aggregate amount of $750,000, pursuant to the amended Convertible Note (see Note 5). | |||||||
| Proceeds from Convertible debt | $ 880,000 | |||||||
| Sponsor [Member] | ||||||||
| Working capital loan repayment description | The Sponsor had agreed to loan the Company an aggregate of up to $300,000 | |||||||
| Working Capital Loan | $ 1,500,000 | |||||||
| Proceeds from Convertible debt | $ 400,000 | $ 350,000 | ||||||
| Subsequent Event [Member] | ||||||||
| Proceeds from Convertible debt | $ 130,000 | |||||||
| Private Placement Warrants [Member] | ||||||||
| Sale of units in initial public offering | 7,760,000 | |||||||
| Sale of units in initial public offering aggragate amount | $ 7,760,000 | |||||||
| Warrants price per share | $ 1.00 | |||||||
| Private Placement Warrants [Member] | Sponsor [Member] | ||||||||
| Sale of units in initial public offering | 7,209,560 | |||||||
| Over-Allotment Option [Member] | ||||||||
| Sale of units in initial public offering | 2,025,000 | |||||||
| Initial Public Offering [Member] | ||||||||
| Sale of units in initial public offering | 15,525,000 | |||||||
| Sale of units per share | $ 10.00 | |||||||
| Sale of units in initial public offering aggragate amount | $ 155,250,000 | |||||||
| Warrants price per share | $ 1.00 | |||||||
| Deferred underwriting commissions | $ 5,433,800 | |||||||
| Offering costs | $ 9,300,000 | |||||||